Inaktiver Wert

Andere Sprachen AKOUOS

Aktien

A2P7Z8

US00973J1016

AKUS

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Akouos, Inc. Announces Positive Initial Clinical Results from the Phase 1/2 AK-OTOF-101 Study	23.01.
AKOUOS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	01.12.22
Akouos, Inc. Announces Executive and Board Changes	01.12.22
Eli Lilly : a finalisé l'acquisition d'Akouos	01.12.22
Lilly Wraps Up Acquisition of Akouos	01.12.22
Akouos, Inc.(NasdaqGS:AKUS) dropped from NASDAQ Composite Index	01.12.22
Eli Lilly and Company completed the acquisition of Akouos, Inc. from a group of shareholders.	01.12.22
Eli Lilly : vers l'acquisition de 81.1% des actions d'Akouos	30.11.22
Eli Lilly's Buyout Offer Accepted by 81% Akouos Shareholders at Closing	30.11.22
Lilly and Akouos Announce Expiration of Akouos Tender Offer	30.11.22
Akouos, Inc.(NasdaqGS:AKUS) dropped from S&P TMI Index	30.11.22
Akouos, Inc.(NasdaqGS:AKUS) dropped from NASDAQ Biotechnology Index	29.11.22
Akouos Q3 Loss Narrows	14.11.22
AKOUOS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14.11.22
Akouos, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14.11.22
AKOUOS, INC. : Results of Operations and Financial Condition (form 8-K)	14.11.22
Akouos Reports Third Quarter 2022 Financial Results and Provides Business Highlights	14.11.22
North American Morning Briefing : Fed Hopes, China -2-	11.11.22
AKOUOS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akouos, Inc. - AKUS	19.10.22
Health Care Up Amid Earnings, Deals -- Health Care Roundup	18.10.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen AKOUOS

Aktien

A2P7Z8

US00973J1016

AKUS

Andere Sprachen

Filter